D
Donald E. Low
Researcher at University of Toronto
Publications - 362
Citations - 25624
Donald E. Low is an academic researcher from University of Toronto. The author has contributed to research in topics: Population & Streptococcus pneumoniae. The author has an hindex of 88, co-authored 359 publications receiving 24384 citations. Previous affiliations of Donald E. Low include Trillium Health Centre & New York City Department of Health and Mental Hygiene.
Papers
More filters
Journal ArticleDOI
Streptococcus pneumoniae infection: a Canadian perspective.
TL;DR: The main goal of this review is to provide an overall picture of invasive pneumococcal diseases in Canada for the past few decades, including serotype changes and shifts in antibiotic resistance patterns.
Journal ArticleDOI
A Comparison of Bacteremic Pneumococcal Pneumonia with Nonbacteremic Community-Acquired Pneumonia of Any Etiology — Results from a Canadian Multicenter Study
TL;DR: While some differences in patient characteristics and presentation occur when patients with bacteremic pneumococcal pneumonia are compared with nonbactereic patients with community-acquired pneumonia, there is considerable overlap, and clinical presentation does not allow one to distinguish the bacterenmic patients from the nonbactseremic patients.
Journal ArticleDOI
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data
George G. Zhanel,Kevin Wolter,Cristina Dana Calciu,Patricia A. Hogan,Donald E. Low,Karl Weiss,James A. Karlowsky +6 more
TL;DR: Clinical cure rates in CARTI subjects treated with azithromycin were higher for Azi-S SPN compared withAzi-R SPN, and the cure rates were not different for subjects infected with LLAR-SPN versus HLAR- SPN.
Journal ArticleDOI
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci
Gordon L. Archer,Pierre Auger,Gary V. Doern,Mary Jane Ferraro,Peter C. Fuchs,James H. Jorgensen,Donald E. Low,Patrick R. Murray,L. Barth Reller,Charles W. Stratton,Christine Wennersten,Robert C. Moellering +11 more
TL;DR: RP 59500 was highly active (MIC90 < or = 2 micrograms/ml) against all strains, including those that were resistant to oxacillin, ciprofloxacin, erythromycin, and spiramycin.
Journal Article
The prevalence of Campylobacter pylori gastritis among asymptomatic adults
D. B. Gregson,Donald E. Low,M. M. Cohen,N. B. Cooter,J. J. Connon,Stephen L. Wolman,Andrew E. Simor +6 more
TL;DR: It is concluded that the prevalence of C. pylori-associated gastritis among symptomatic patients increases with age and that the organism may be present in the gastrointestinal tract for prolonged periods without symptoms or evidence of disease progression.